FDA Drug recall D-609-2013
Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL) ADD-Vantage Vial, Rx…
- FDA Drug
- Class II
- terminated
- Published 2013-06-26
On 2013-06-26 the FDA classified a Class II recall of Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL) ADD-Vantage Vial, Rx… by Pharmacia And Upjohn, citing presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-609-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-06-04 |
| Published | 2013-06-26 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Pharmacia And Upjohn |
| Distribution | US |
Product
Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL) ADD-Vantage Vial, Rx Only, For Intravenous Use Only, Use Only with the ADD-Vantage diluent container, Distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc, NY, NY 10017, NDC a) 0009-3124-03 and b) 0009-3447-03
Reason
Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.
Identifiers
| ndc | 0009-0870-21 |
|---|---|
| ndc | 0009-0870-26 |
| ndc | 0009-0775-20 |
| ndc | 0009-0775-26 |
| ndc | 0009-0902-11 |
| ndc | 0009-0902-18 |
| ndc | 0009-0728-05 |
| ndc | 0009-0728-09 |
| ndc | 0009-3124-01 |
| ndc | 0009-3124-03 |
| ndc | 0009-3447-01 |
| ndc | 0009-3447-03 |
| ndc | 0009-3381-01 |
| ndc | 0009-3381-02 |
| ndc | 0009-3375-01 |
| ndc | 0009-3375-02 |
| ndc | 0009-3382-01 |
| ndc | 0009-3382-02 |
| ndc | 0009-6582-02 |
| ndc | 0009-6582-01 |
| code_info | Lots: a) G34908, Exp 06/14; G53479, Exp 09/14; G63442, G58347, Exp 10/14; G80133, Exp 12/14; and b) G34910, Exp 06/14;…Lots: a) G34908, Exp 06/14; G53479, Exp 09/14; G63442, G58347, Exp 10/14; G80133, Exp 12/14; and b) G34910, Exp 06/14; G36879, G41005, Exp 07/14; G53478, Exp 09/14; G63444, Exp 10/14; G76317, Exp 11/14. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-609-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.